Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The study is aimed to evaluate the additional role of ciprofloxacin therapy in severe
alcoholic hepatitis combined to prednisolone therapy in an open-label placebo controlled
manner.